Literature DB >> 2688970

Antithrombotic therapy in cardiac disease. An emerging approach based on pathogenesis and risk.

B Stein1, V Fuster, J L Halperin, J H Chesebro.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688970     DOI: 10.1161/01.cir.80.6.1501

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

Review 1.  Non-rheumatic atrial fibrillation: warfarin or aspirin for all?

Authors:  J Nolan; P Bloomfield
Journal:  Br Heart J       Date:  1992-12

Review 2.  Use of the activated clotting time in anticoagulation monitoring of intravascular procedures.

Authors:  J Bowers; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1993

Review 3.  Antiplatelet therapy--Part I.

Authors:  S H Goodnight; B M Coull; J H McAnulty; L M Taylor
Journal:  West J Med       Date:  1993-04

Review 4.  Novel antithrombotic therapy.

Authors:  G M Rodgers
Journal:  West J Med       Date:  1993-12

Review 5.  Current guidelines for the treatment of congestive heart failure.

Authors:  F X Kleber; R Wensel
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 6.  Is aspirin underused in myocardial infarction?

Authors:  J M Arnau; A Agustí
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

7.  Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair.

Authors:  Tae-Woong Hwang; Sung-Ook Kim; Sang-Yun Lee; Seong-Ho Kim; Eun-Young Choi; So-Ick Jang; Su-Jin Park; Hye-Won Kwon; Hyo-Bin Lim; Chang-Ha Lee; Eun-Seok Choi
Journal:  Korean J Pediatr       Date:  2016-11-18

Review 8.  From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.

Authors:  Yu-Ju Kuo; Ching-Hu Chung; Tur-Fu Huang
Journal:  Toxins (Basel)       Date:  2019-06-26       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.